Scholar Rock, based in Cambridge, MA, is a biopharmaceutical company dedicated to revolutionizing therapeutic approaches through innovative science and a unique drug discovery platform. With a focus on protein growth factors, Scholar Rock aims to advance the standard of care for neuromuscular diseases and other conditions where growth factor-targeted drugs can make a significant impact.
Through a decade of research and development, Scholar Rock has built a promising pipeline of product candidates targeting a range of serious diseases such as spinal muscular atrophy, oncology, anemia, and fibrosis. By shining new light on overlooked areas of medicine, the company is committed to discovering, developing, and delivering life-changing therapies that have the potential to transform patient outcomes.
Generated from the website